VALUE OF DELAYED-HYPERSENSITIVITY INDEX IN PATIENTS WITH MALIGNANCY

1 January 1977

journal article
research article

Vol. 38 (3) , 182-184

Abstract

A delayed hypersensitivity index can be obtained by standardized in vivo testing with available antigens. Recall antigens and DNCB [dinitrochlorobenzene] can be used to assess the afferent limb. The index is a valid indicator of cellular immunity, which is important as a dynamic indicator in many medical conditions and in treating patients with malignancy.

This publication has 0 references indexed in Scilit: